Abstracts

Citation

C MacBrayne, R Rutstein, R Yogev, A Wiznia, L Fairlie, B Graham, C Alvero, J Moye, E Townley, H Crauwels, X Woot de Trixhe, L Tambuyzer, S Vanveggel, M Opsomer, J Kiser. Etravirine pharmacokinetics in treatment-experienced HIV-infected children =12 mos to 6 yrs. Presented at: CROI 2018; 2018 Mar 06.

Citation

MacBrayne CE, Rutstein R, Yogev R, Wiznia A, Fairlie L, Graham B, Alvero C, Moye J, Townley E, Crauwels H, Woot de Trixhe X, Tambuyzer L, Vanveggel S, Opsomer M, Kiser JJ. Etravirine pharmacokinetics in treatmentexperienced HIV-infected children =12 mos to 6 yrs. Presented at: CROI 2018; 2018 Mar 07.

Citation

L Mao, S LaCourse, S Kim, C Liu, W Jiao, CJ Lyon, S Nachman, CD Mitchell, Y Hu. Evaluation of a Blood-based Antigen Test for Tuberculosis in Infants. Presented at: CROI 2020.

Citation

M Lesosky, JM Raboud, T Glass, S Brummel, AL Ciaranello, JS Currier, S Essajee, DV Havlir, CA Koss, A Ogwu, RL Shapiro, EJ Abrams, L Myer. Evaluation of guidelines for VL monitoring in pregnancy & breastfeeding: a simulation. Presented at: CROI 2019; 2019 Mar 07.

Citation

Mary Culnane, C.R.N.P., M.S., Mary Glenn Fowler, M.D., M.P.H., Sophia S. Lee, M.S., George D. McSherry, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Steven Gortmaker, Ph.D., David E. Shapiro, Ph.D., Karen J. O'Donnell, Ph.D., Bethann Cunningham-Schrader, B.A., M.S., James M. Oleske, M.D. Evaluation Of Late Effects Of In Utero (IU) ZDV Exposure Among Uninfected Infants Born To HIV+ Women Enrolled In ACTG 076 & 219. Presented at: 35th Infectious Diseases Society of America Annual Meeting.

Citation

Ursula J. Buchholz, Coleen K. Cunningham, Ruth A. Karron, Elizabeth J. McFarland, Mark J. Giganti, Rachel Ketchum, Charlotte Perlowski, Jennifer Libous, Haley Brozik, Jennifer Oliva, Dwight E. Yin, Patrick Jean-Philippe, Jack Moye Jr., Vivian Rexroad, Benjamin Johnston, Grace Malonga, Xueqiao Liu, Lijuan Yang, Cindy Luongo, Peter L. Collins, IMPAACT 2021 Study Team. Evaluation of Live Intranasal Respiratory Syncytial Virus (RSV) Vaccines RSV/DeltaNS2/Delta1313/I1314L, RSV/6120/DeltaNS2/1030s, and RSV/276 in RSV-Seronegative Children. Presented at: RSV Vaccines for the World Conference; 2026 Feb 20.

Citation

Saroj S. Bakshi, M.D. Evaluation of Pharmacokinetics (PK), Safety, Tolerance and Activity of Combination of Zalcitabine (ddC) and Zidovudine (ZDV) in Stable, ZDV-Treated, Pediatric Patients with HIV Infection.

Citation

Ursula J. Buchholz, Ruth A. Karron, Petronella Muresan, Matthew S. Kelly, Elizabeth J. McFarland, Charlotte Perlowski, Jennifer Libous, Jennifer Oliva, Patrick Jean-Philippe, Jack Moye Jr., Elizabeth Schappell, Emily Barr, Vivian Rexroad, Benjamin Johnston, Ellen G. Chadwick, Mikhaela Cielo, Mary Paul, Jaime G. Deville, Mariam Aziz, Lijuan Yang, Cindy Luongo, Peter L. Collins, Coleen K. Cunningham, IMPAACT 2018 Study Team. Evaluation of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccines RSV/?NS2/?1313/I1314L and RSV/276 in RSV Seronegative Children. Presented at: 12th International Respiratory Syncytial Virus Symposium.

Citation

Evaluation of Zidovudine (ZDV) Efficacy in Children by Surrogate Markers (Neopterin, P24AG, and CD4 Count).

Citation

R. Watchi. Evaluation of Zidovudine (ZDV) Efficacy in Children by Surrogate Markers (Neopterin, P24AG, and CD4 Count).